Healthcare News and Research

Latest Healthcare News and Research

Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Bayer today unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America Scientific Assembly and Annual Meeting. The enhanced version has new features that can help radiologists and hospital administrators meet new 2015 U.S. Joint Commission Diagnostic Imaging Standards, providing information to help optimize radiation dose management and contrast dose analytics to advance image quality and patient care.

1 Dec 2014

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

From Baxter International Inc. 1 Dec 2014

Philips introduces new lung screening solution at RSNA 2014

Royal Philips today introduced a new lung screening solution designed to offer health care providers a faster and more definitive pathway to lung cancer detection and treatment. Making its debut at the 2014 Radiological Society of North America Annual Meeting in Chicago this week, this total solution is comprised of products and services that enable health care providers to implement and manage a comprehensive computed tomography (CT) lung screening program which tracks and guides patients across the health continuum.

1 Dec 2014

Eylea receives Health Canada approval for treatment of CRVO and DME

Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).

1 Dec 2014

Cepheid gets FDA clearance to market Xpert Norovirus

Cepheid today announced it has received clearance from the U.S. Food & Drug Administration to market Xpert Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII).

1 Dec 2014

Eli Lilly, AstraZeneca begin AZD3293 Phase II/III study for treatment of early Alzheimer's disease

Eli Lilly and Company and AstraZeneca today announced enrollment of the first patient into AMARANTH, a Phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease.

1 Dec 2014

IMRIS successfully completes human factors study for SYMBIS Surgical System

IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26.

1 Dec 2014

Endomagnetics gets FDA's IDE approval to begin clinical trial of SentiMag and Sienna+ system

Cancer healthcare company Endomagnetics announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration to initiate a pivotal clinical trial to evaluate the safety and effectiveness of the SentiMag and Sienna+ magnetic sentinel lymph node biopsy system in the management of breast cancer.

1 Dec 2014

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

A quality improvement initiative improved the outcomes of patients undergoing cardiac surgery at select medical centers in northern New England, according to a study in the December issue of Critical Care Nurse (CCN).

1 Dec 2014

DaVita HealthCare Partners earns over 30 awards for excellence in 2014

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, today confirmed earning over 30 awards for excellence from independent organizations in 2014.

1 Dec 2014

Sanovas's endoscopic imaging platform recognized by Frost & Sullivan

Based on its recent analysis of the endoscopic imaging market, Frost & Sullivan recognizes Sanovas Inc. with the 2014 Global Frost & Sullivan Award for New Product Innovation Leadership. In a market where spiralling healthcare costs impact the entire spectrum of stakeholders, Sanovas's ground-breaking endoscopic platform, MicroCam, provides the functionality of a high-end, flexible endoscope without the accompanying cost and maintenance burden.

1 Dec 2014

Defining Excellence in Simulation Programs: A comprehensive book for healthcare professionals

Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.

1 Dec 2014

Leading experts to discuss specific strategies to combat Ebola

Where do we stand in the fight against Ebola -- and what should be done now?

1 Dec 2014

CTI BioPharma announces upcoming presentations of pacritinib data at ASH Annual Meeting

CTI BioPharma Corp. (CTI) today announced the upcoming presentations of data highlighting pacritinib, an oral multikinase inhibitor with dual activity against JAK2 and FLT3, and tosedostat, an oral selective inhibitor of aminopeptidases, at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 6-9 in San Francisco, CA.

1 Dec 2014

CCR5 receptor plays key role in driving prostate cancer metastases

Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. In a study published online December 1st in the journal Cancer Research, researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone.

1 Dec 2014

New vaccine shows promise in patients with metastatic breast cancer

A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients' immune systems to attack tumor cells and helped slow the cancer's progression.

1 Dec 2014

Health Canada updates Canadians regarding sale of unlicensed HIV test kits via Amazon.ca.

Health Canada is informing Canadians that multiple distributors (Positive Health, dailySupply, BestDealCA, eshopic, Urban Inspirations, grabthesale, and dealkings) are selling the unlicensed "OraQuick in Home HIV Test" kit via Amazon.ca.

29 Nov 2014

Pivotal Therapeutics announces accomplishments, financial results for Q3 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its accomplishments and financial results for the three months ended September 30, 2014.

29 Nov 2014

CHP Canada commends launch of consultations on proposed consumer health products

Consumer Health Products Canada (CHP Canada) applauds federal Health Minister Rona Ambrose for beginning consultations on a proposed consumer health products framework.

29 Nov 2014

Roche Holdings declares final results of its previously announced tender offer

Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.

29 Nov 2014

Healthcare News and Research

Latest Healthcare News and Research

Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Philips introduces new lung screening solution at RSNA 2014

Eylea receives Health Canada approval for treatment of CRVO and DME

Cepheid gets FDA clearance to market Xpert Norovirus

Eli Lilly, AstraZeneca begin AZD3293 Phase II/III study for treatment of early Alzheimer's disease

IMRIS successfully completes human factors study for SYMBIS Surgical System

Endomagnetics gets FDA's IDE approval to begin clinical trial of SentiMag and Sienna+ system

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

DaVita HealthCare Partners earns over 30 awards for excellence in 2014

Sanovas's endoscopic imaging platform recognized by Frost & Sullivan

Defining Excellence in Simulation Programs: A comprehensive book for healthcare professionals

Leading experts to discuss specific strategies to combat Ebola

CTI BioPharma announces upcoming presentations of pacritinib data at ASH Annual Meeting

CCR5 receptor plays key role in driving prostate cancer metastases

New vaccine shows promise in patients with metastatic breast cancer

Health Canada updates Canadians regarding sale of unlicensed HIV test kits via Amazon.ca.

Pivotal Therapeutics announces accomplishments, financial results for Q3 2014

CHP Canada commends launch of consultations on proposed consumer health products

Roche Holdings declares final results of its previously announced tender offer

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in